Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of $10.87B. The enterprise value is $79.71B.
Market Cap$10.87B
Enterprise Value$79.71B
Share Statistics
CSPC Pharmaceutical Group has 11,522,452,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,522,452,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CSPC Pharmaceutical Group’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 11.33%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)11.33%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.38M
Profits Per Employee215.20K
Employee Count21,400
Asset Turnover0.63
Inventory Turnover2.66
Valuation Ratios
The current PE Ratio of CSPC Pharmaceutical Group is 20.4. CSPC Pharmaceutical Group’s PEG ratio is -0.53.
PE Ratio20.4
PS Ratio1.90
PB Ratio1.63
Price to Fair Value1.63
Price to FCF30.23
Price to Operating Cash Flow17.06
PEG Ratio-0.53
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of 29.54B and earned 4.41B in profits. Earnings per share was 0.38.
Revenue29.54B
Gross Profit20.67B
Operating Income5.45B
Pretax Income5.68B
Net Income4.41B
EBITDA7.18B
Earnings Per Share (EPS)0.38
Cash Flow
In the last 12 months, operating cash flow was 4.73B and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow4.73B
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
CSPC Pharmaceutical Group pays an annual dividend of $0.018, resulting in a dividend yield of 3.15%
Dividend Per Share$0.018
Dividend Yield3.15%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change53.12%
50-Day Moving Average1.13
200-Day Moving Average0.89
Relative Strength Index (RSI)40.75
Average Volume (3m)14.41K
Important Dates
CSPC Pharmaceutical Group upcoming earnings date is Nov 20, 2025, TBA (Confirmed).
Last Earnings DateAug 22, 2025
Next Earnings DateNov 20, 2025
Ex-Dividend DateOct 21, 2025
Financial Position
CSPC Pharmaceutical Group as a current ratio of 2.27, with Debt / Equity ratio of 1.49%
Current Ratio2.27
Quick Ratio1.95
Debt to Market Cap<0.01
Net Debt to EBITDA-0.87
Interest Coverage Ratio124.82
Taxes
In the past 12 months, CSPC Pharmaceutical Group has paid 1.26B in taxes.
Income Tax1.26B
Effective Tax Rate0.22
Enterprise Valuation
CSPC Pharmaceutical Group EV to EBITDA ratio is 6.94, with an EV/FCF ratio of 26.86.
EV to Sales1.69
EV to EBITDA6.94
EV to Free Cash Flow26.86
EV to Operating Cash Flow10.99
Balance Sheet
CSPC Pharmaceutical Group has $8.25B in cash and marketable securities with $507.33M in debt, giving a net cash position of $7.74B billion.
Cash & Marketable Securities$8.25B
Total Debt$507.33M
Net Cash$7.74B
Net Cash Per Share$0.67
Tangible Book Value Per Share$2.83
Margins
Gross margin is 69.96%, with operating margin of 18.45%, and net profit margin of 14.92%.
Gross Margin69.96%
Operating Margin18.45%
Pretax Margin19.23%
Net Profit Margin14.92%
EBITDA Margin24.30%
EBIT Margin19.69%
Analyst Forecast
The average price target for CSPC Pharmaceutical Group is $1.43, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.43
Price Target Upside45.92% Upside
Analyst ConsensusHold
Analyst Count17
Revenue Growth Forecast―
EPS Growth Forecast―